Bulletin
Investor Alert

New York Markets Close in:

Sesen Bio Inc.

NAS: SESN

GO
/marketstate/country/us

Countdown to close

 --Real time quotes

May 27, 2022, 3:23 p.m.

/zigman2/quotes/201402704/composite

$

0.52

Change

-0.0038 -0.73%

Volume

Volume 2.38m

Real time quotes

/zigman2/quotes/201402704/composite

Previous close

$ 0.52

$ 0.52

Change

-0.0038 -0.73%

Day low

Day high

$0.49

$0.53

Open

52 week low

52 week high

$0.37

$6.04

Open

Company Description

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company...

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Valuation

P/E Ratio (with extraordinary items)

1.92

Price to Sales Ratio

5.60

Price to Book Ratio

0.95

Enterprise Value to EBITDA

2.08

Enterprise Value to Sales

-2.63

Efficiency

Total Asset Turnover

0.11

Liquidity

Current Ratio

17.77

Quick Ratio

17.77

Cash Ratio

14.06

Profitability

Gross Margin

99.68

Operating Margin

-106.09

Pretax Margin

-32.43

Net Margin

-1.27

Return on Assets

-0.13

Return on Equity

-0.41

Return on Total Capital

-34.66

Capital Structure

Officers and Executives

Name Age Officer Since Title
Dr. Thomas R. Cannell 59 2018 President, Chief Executive Officer & Director
Ms. Monica Forbes 45 2019 Chief Financial Officer & Vice President
Ms. Stephanie Vigue - 2022 Finance Director
Dr. Jeannick Cizeau - 2005 Head of Research
Mr. Chèrie Kaefring - 2021 Director-Clinical Operations

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/18/2022 Thomas R. Cannell
President and CEO; Director
606,800   Award at $0 per share. 0
02/18/2022 Monica Forbes
Chief Financial Officer
542,250   Award at $0 per share. 0
02/18/2022 Mark R. Sullivan
General Counsel & Secretary
339,525   Award at $0 per share. 0
02/18/2022 Glen C. MacDonald
Chief Technology Officer
308,925   Award at $0 per share. 0
02/18/2022 Elly Ryu
Principal Accounting Officer
86,300   Award at $0 per share. 0
10/01/2021 Elly Ryu
Principal Accounting Officer
115,000   Award at $0 per share. 0
/news/latest/company/us/sesn

MarketWatch News on SESN

/news/nonmarketwatch/company/us/sesn

Other News on SESN

  1. Axcella (AXLA) Up on Decision to Prioritize Long-COVID Program

    10:20 a.m. Today

    - Zacks.com

  2. Reata (RETA) Friedreich's Ataxia NDA Gets Priority Review

    9:26 a.m. Today

    - Zacks.com

  3. Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates

    9:08 a.m. May 17, 2022

    - Zacks.com

  4. 10-Q: SESEN BIO, INC.

    8:06 a.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. 10-K: SESEN BIO, INC.

    9:57 a.m. Feb. 28, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  6. The State Of Biotech In 2022

    5:04 a.m. Jan. 3, 2022

    - Seeking Alpha

  7. Loading more headlines...

At a Glance

Sesen Bio, Inc.

245 First Street

Suite 1800

Cambridge, Massachusetts 02142

Phone

1 6174448550

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

$26.54M

Net Income

$-336,000

Employees

35.00

/news/pressrelease/company/us/sesn

Press Releases on SESN

  1. 10 Top Penny Stocks To Buy For Under $1 May 2022 Edition

    6:59 p.m. May 5, 2022

    - Penny Stocks

  2. 3 Penny Stocks That Pushed Up During Trading Today

    5:49 p.m. May 5, 2022

    - Penny Stocks

  3. Hot Penny Stocks To Buy For Under $1 This Week

    2:49 p.m. May 3, 2022

    - Penny Stocks

  4. Sesen Bio Provides Strategic Update

    8:00 a.m. May 3, 2022

    - BusinessWire - BZX

  5. Sesen Bio Further Enhances Team with Key Hires

    9:00 a.m. Jan. 10, 2022

    - BusinessWire - BZX

  6. Sesen Bio Strengthens Medical Team

    9:00 a.m. Nov. 29, 2021

    - BusinessWire - BZX

  7. 22nd Century Group Announces CFO Transition

    9:30 a.m. Nov. 19, 2021

    - GlobeNewswire

  8. Sesen Bio Announces Productive CMC Type A Meeting with the FDA

    8:00 a.m. Nov. 1, 2021

    - BusinessWire - BZX

  9. Loading more headlines...
Link to MarketWatch's Slice.